Neurotensin: Dual roles in psychostimulant and antipsychotic drug responses

Life Sciences

Volumn 73, Issue 6, 2003, Pages 801-811

  Dobner, Paul R ^a   Deutch, Ariel Y ^b   Fadel, Jim ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic drugs; Dopamine D2 receptors; Neurotensin; Psychostimulants

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID; AMPHETAMINE; CLOZAPINE; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; GLUTAMIC ACID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NEUROTENSIN; NEUROTENSIN RECEPTOR; PROTEIN FOS; PSYCHOSTIMULANT AGENT;

ADAPTATION; ANALGESIA; ATTENUATION; BASAL GANGLION; CATALEPSY; CELL SUBPOPULATION; COGNITION; COMPULSION; CONFERENCE PAPER; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EXPOSURE; DRUG RESPONSE; EXTRACELLULAR SPACE; EXTRAPYRAMIDAL SYSTEM; GENE EXPRESSION; GENE TARGETING; HYPOTHERMIA; HYPOTHESIS; KNOCKOUT MOUSE; LOCOMOTION; MOTOR DYSFUNCTION; MUSCLE RELAXATION; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PSYCHOSIS; RECEPTOR AFFINITY; REWARD; SCHIZOPHRENIA; SENSITIZATION; SIGNAL TRANSDUCTION; STEREOTYPY; STRIATE CORTEX; SUBSTANTIA NIGRA; TARDIVE DYSKINESIA;

EID: 0038512297     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00411-9     Document Type: Conference Paper

References (82)

1. Alexander M.J., Leeman S.E. Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor. Journal of Comparative Neurology. 402:1998;475-500.
2. Betancur C., Cabrera R., de Kloet E.R., Pelaprat D., Rostene W. Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine. Neuropsychopharmacology. 19:1998;322-332.
3. 3 receptor deficient mice. Neuropsychopharmacology. 24:2001;170-182.
4. Betancur C., Rostene W., Berod A. Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum. Molecular Brain Research. 44:1997;334-340.
5. Binder E., Kinkead B., Owens M.J., Kilts C.D., Nemeroff C.B. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating. Journal of Neuroscience. 21:2001;601-608.
6. Binder E.B., Kinkead B., Owens M.J., Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacological Reviews. 53:2001;453-486.
7. Binder E.B., Kinkead B., Owens M.J., Nemeroff C.B. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs. Biological Psychiatry. 50:2001;856-872.
8. Binder E.B., Gross R.E., Nemeroff C.B., Kilts C.D. Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats. Psychopharmacology. 161:2002;288-295.
9. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
10. Boudin H., Pélaprat D., Rostène W., Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. Journal of Comparative Neurology. 373:1996;76-89.
11. Cadoni C., Pinna A., Russi G., Consolo S., Di Chiara G. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience. 65:1995;1027-1039.
12. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nature Neuroscience. 3:2000;377-383.
13. Castel M.-N., Morino P., Nylander I., Terenius L., Hökfelt T. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat. Europrean Journal of Pharmacology. 262:1994;1-10.
14. Castel M.N., Morino P., Dagerlind Å., Hökfelt T. Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment. European Journal of Neuroscience. 6:1994;646-656.
15. Costa F.G., Frussa-Filho R., Felicio L.F. The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioral sensitisation in mice. European Journal of Pharmacology. 428:2001;97-103.
16. Daly D.A., Moghaddam B. Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats. Neuroscience Letters. 152:1993;61-64.
17. De Souza I.E.J., Meredith G.E. NMDA receptor blockade attenuates the haloperidol induction of Fos protein in the dorsal but not the ventral striatum. Synapse. 32:1999;243-253.
18. Del Arco A., Gonzalez-Mora J.L., Armas V.R., Mora F. Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms. Neuropharmacology. 38:1999;943-954.
19. Deutch A.Y. Sites and mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression. Deutch A.Y. Handbook of Experimental Pharmacology: Antipsychotics. 1996;117-161 Springer, Berlin.
20. Diaz-Cabiale Z., Fuxe K., Narvaez J.A., Finetti S., Antonelli T., Tanganelli S., Ferraro L. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist. NeuroReport. 13:2002;763-766.
21. Dobner P.R., Fadel J., Deitemeyer N., Carraway R.E., Deutch A.Y. Neurotensin-deficient mice show altered responses to antipsychotic drugs. Proceedings of the National Academy of Science USA. 98:2001;8048-8053.
22. Dobner P.R., Fadel J., Deutch A.Y. Amphetamine-evoked Fos expression is significantly attenutated in the medial striatum of neurotensin knockout mice. Society for Neuroscience Abstracts. 31:2001;512.
23. Dubuc I., Sarret P., Labbe-Jullie C., Botto J.-M., Honore E., Bourdel E., Martinez J., Costentin J., Vincent J.-P., Kitabgi P., Mazella J. Identification of the receptor subtype involved in the analgesic effect of neurotensin. Journal of Neuroscience. 19:1999;503-510.
24. Ervin G.N., Birkemo L.S., Nemeroff C.B., Prange A.J. Jr. Neurotensin blocks certain amphetamine-induced behaviors. Nature. 291:1981;73-76.
25. Fadel J., Dobner P.R., Deutch A.Y. The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat. Neuroscience Letters. 303:2001;17-20.
26. Feifel D., Minor K.L., Dulawa S., Swerdlow N.R. The effects of intra-accumbens neurotensin on sensorimotor gating. Brain Research. 760:1997;80-84.
27. Ferraro L., Antonelli T., O'Connor W.T., Fuxe K., Soubrie P., Tanganelli S. The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. Journal of Neuroscience. 18:1998;6977-6989.
28. Ferraro L., O'Connor W.T., Antonelli T., Fuxe K., Tanganelli S. Differential effects of intrastriatal neurotensin (1-13) and neurotensin (8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat. European Journal of Neuroscience. 9:1997;1838-1846.
29. Ferraro L., Tanganelli S., O'Connor W.T., Bianchi C., Ungerstedt U., Fuxe K. Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. Synapse. 20:1995;362-364.
30. Ferraro L., Tomasini M.C., Fernandez M., Bebe B.W., O'Connor W.T., Fuxe K., Glennon J.C., Tanganelli S., Antonelli T. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain. Neuroscience. 102:2001;113-120.
31. Garver D.L., Bissette G., Yao J.K., Nemeroff C.B. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. American Journal of Psychiatry. 148:1991;484-488.
32. Gray A.M., Rawls S.M., Shippenberg T.S., McGinty J.F. The κ-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. Journal of Neurochemistry. 73:1999;1066-1074.
33. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proceedings of the National Academy of Science USA. 87:1990;6912-6916.
34. Harrison R.J., McNeil G.P., Dobner P.R. Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins. Molecular Endocrinology. 9:1995;981-993.
35. Horger B.A., Taylor J.R., Elsworth J.D., Roth R.H. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology. 11:1994;215-222.
36. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacological Reviews. 47:1995;133-178.
37. Hussain N., Flumerfelt B.A., Rajakumar N. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience. 102:2001;391-399.
38. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. Journal of Neuroscience. 18:1998;1979-1986.
39. Kalivas P.W., Burgess S.K., Nemeroff C.B., Prange A.J. Jr. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience. 8:1983;495-505.
40. Kalivas P.W., Taylor A. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Research. 358:1985;70-76.
41. Meltzer H.Y., Deutch A.Y. Neurochemistry and neurobiology of schizophrenia. Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., Uhler M.D. Basic neurochemistry: molecular, cellular, and medical aspects. 1999;1053-1072 Lippincott-Raven, New York.
42. Merchant K.M. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum. Molecular and Cellular Neuroscience. 5:1994;336-344.
43. Merchant K.M., Dobie D.J., Filloux F.M., Totzke M., Aravagiri M., Dorsa D.M. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. Journal of Pharmacology and Experimental Therapeutics. 271:1994;460-471.
44. Merchant K.M., Dobner P.R., Dorsa D.M. Differential effects of haloperidol and clozapine on neurotensin gene transcription in the rat neostriatum. Journal of Neuroscience. 12:1992;652-663.
45. Merchant K.M., Hanson G.R., Dorsa D.M. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. Journal of Pharmacology and Experimental Therapeutics. 269:1994;806-812.
46. Merchant K.M., Miller M.A. Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol. Molecular Brain Research. 23:1994;271-277.
47. Miele M., Mura M.A., Enrico P., Esposito G., Serra P.A., Migheli R., Zangani D., Miele E., Desole M.S. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats. British Journal of Pharmacology. 129:2000;582-588.
48. Mora F., Porras A. Effects of amphetamine on the release of excitatory amino acid neurotransmitters in the basal ganglia of the conscious rat. Canadian Journal of Physiology and Pharmacology. 71:1993;348-351.
49. Nash J.F., Yamamoto B.K. Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats. Brain Research. 627:1993;1-8.
50. Nemeroff C.B. Neurotensin: perchance an endogenous neuroleptic? Biological Psychiatry. 15:1980;283-302.
51. O'Connor W.T., Tanganelli S., Ungerstedt U., Fuxe K. The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo microdialysis study. Brain Research. 573:1992;209-216.
52. Panayi F., Dorso E., Lambas-Senas L., Renaud B., Scarna H., Berod A. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine. Neuropsychopharmacology. 26:2001;64-74.
53. Pehek E.A. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. Journal of Pharmacology and Experimental Therapeutics. 289:1999;14-23.
54. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., Mallorga P.J., Pascarella D.M., Snyder M.A., Williams J.B., Zeng Z. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. Journal of Pharmacology and Experimental Therapeutics. 300:2002;305-313.
55. Pickel V.M., Chan J., Delle Donne K.T., Boudin H., Pelaprat D., Rostene W. High-affinity neurotensin receptors in the rat nucleus accumbens: subcellular targeting and relation to endogenous ligand. Journal of Comparative Neurology. 435:2001;142-155.
56. Pilotte N.S., Mitchell W.M., Sharpe L.G., De Souza E.B., Dax E.M. Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain. Synapse. 9:1991;111-120.
57. Rawls S.M., McGinty J.F. Delta opioid receptors regulate calcium-dependent amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study. Brain Research. 861:2000;296-304.
58. Reid M.S., Hsu K.J., Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse. 27:1997;95-105.
59. Remaury A., Vita N., Gendreau S., Jung M., Arnone M., Poncelet D., Culouscou J.-M., Le Fur G., Soubrie P., Caput D., Shire D., Kopf M., Ferrara P. Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Research. 953:2002;63-72.
60. Robertson G.S., Tetzlaff W., Bedard A., St.-Jean M., Wigle N. c-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. Neuroscience. 67:1995;325-344.
61. Rogue P., Vincendon G. Dopamine D2 receptor antagonists induce immediate early genes in the rat striatum. Brain Research Bulletin. 29:1992;469-472.
62. Rompre P.-P. Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine. European Journal of Pharmacology. 328:1997;131-134.
63. Rompre P.-P., Perron S. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization. Neuropharmacology. 39:2000;1880-1892.
64. 2 dopamine receptor activation. Synapse. 18:1994;233-240.
65. Schad C.A., Justice J.B. Jr., Holtzman S.G. Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions. Journal of Pharmacology and Experimental Therapeutics. 300:2002;932-938.
66. Schmitz Y., Lee C.J., Schmauss C., Gonon F., Sulzer D. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. Journal of Neuroscience. 21:2001;5916-5924.
67. See R.E., Chapman M.A. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. European Journal of Pharmacology. 263:1994;269-276.
68. See R.E., Lynch A.M. Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex. NeuroReport. 6:1995;1795-1798.
69. Sharma R.P., Janicak P.G., Bissette G., Nemeroff C.B. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder. American Journal of Psychiatry. 154:1997;1019-1021.
70. Sharp T., Zetterstrom T., Ljungberg T., Ungerstedt U. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo. European Journal of Pharmacology. 129:1986;411-415.
71. Shearman L.P., Weaver D.R. Haloperidol regulates neurotensin gene expression in striatum of c-fos-deficient mice. Molecular Brain Research. 47:1997;275-285.
72. Stoessl A.J. Effects of neurotensin in a rodent model of tardive dyskinesia. Neuropharmacology. 34:1995;457-462.
73. Torres G., Rivier C. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Research Bulletin. 30:1992;173-176.
74. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 151:2000;99-120.
75. Vincent J.P., Mazella J., Kitabgi P. Neurotensin and neurotensin receptors. Trends in Pharmacological Sciences. 20:1999;302-309.
76. Vita N., Oury-Donat F., Chalon P., Guillemot M., Kaghad M., Bachy A., Thurneyssen O., Garcia S., Poinot-Chazel C., Casellas P., Keane P., Le Fur G., Maffrand J.P., Soubrie P., Caput D., Ferrara P. Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. European Journal of Pharmacology. 360:1998;265-272.
77. Wagstaff J.D., Gibb J.W., Hanson G.R. Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis. Brain Research. 721:1996;196-203.
78. Wagstaff J.D., Gibb J.W., Hanson G.R. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens. Journal of Pharmacology and Experimental Therapeutics. 278:1996;547-554.
79. Wagstaff J.D., Gibb J.W., Hanson G.R. Role of dopamine D1-and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens. Brain Research. 748:1997;241-244.
80. Yamamoto B.K., Cooperman M.A. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. Journal of Neuroscience. 14:1994;4159-4166.
81. Zahm D.S. Neurotensin-immunoreactive neurons in the ventral striatum of the adult rat: ventromedial caudate-putamen, nucleus accumbens and olfactory tubercle. Neuroscience Letters. 81:1987;41-47.
82. Zahm D.S., Williams E.S., Krause J.E., Welch M.A., Grosu D.S. Distinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat. Journal of Comparative Neurology. 400:1998;487-503.